Our commitment to evidence
Every claim on MetaBa traces to peer-reviewed clinical research. We've built a private library of GLP-1 studies — randomized trials, meta-analyses, and real-world evidence — and we read the source material before we write the articles. This is a content standard, not a marketing promise.
Why this matters
Over 30 million Americans take GLP-1 medications. Most get their information from social media, forums, and SEO content — not from the clinical studies that actually describe how these drugs work. Misinformation is everywhere. Paywalls and jargon keep the real evidence inaccessible.
MetaBa exists to close that gap. We take what's locked in peer-reviewed journals and translate it — accurately, carefully, and without sacrificing nuance — into language a patient can act on.
Our editorial principles
- Evidence over opinionIf we don't have a citation, we don't make the claim. No "experts say." No anecdotes dressed up as research.
- Accessible by default, clinical on demandPlain language is the primary experience. Study details are one click away for readers who want them.
- Doctors are allies, not adversariesWe never frame content as "what your doctor won't tell you." Our goal is to help patients have better conversations with their providers — not to replace them.
- Transparent about conflictsMetaBa is not funded by, partnered with, or editorially influenced by any pharmaceutical company. We're pro-evidence, not pro-pharma or anti-pharma.
- Honest about uncertaintyWhen the evidence is mixed, weak, or preliminary, we say so. We don't smooth over gaps to sound more confident.
Who writes this
MetaBa is built by the team behind Scientific Animations — a 22-year medical animation and e-learning company whose clients include many of the world's largest pharmaceutical and medical device manufacturers. Our entire business has been translating complex medical science into content healthcare professionals and patients can understand.
MetaBa is the application of that expertise to the biggest metabolic health development in a generation. We're not new to this — we're a science communication team that's been doing it for decades.